Condition

Squamous Non-small-cell Lung Cancer clinical trials and research

• 6Clinical trials
• 21Countries

Newest Squamous Non-small-cell Lung Cancer clinical trials

All recruiting trials (6)

• Intismeran autogene plus pembrolizumab and chemotherapy for metastatic squamous non-small cell lung cancer

  This trial will test whether adding intismeran autogene to pembrolizumab and chemotherapy helps people with treatment‑naive metastatic squamous non‑small cell lung cancer live longer and keep their cancer from growing.

  Recruiting at 55 sites Phase 2 Merck Sharp & Dohme LLC · Tampa, Florida and 54 other locations · NCT07221474

• ALE.P03 alone for adults with advanced CLDN1-positive solid tumors

  This trial tests whether ALE.P03 given alone is safe and can shrink tumors in adults with advanced CLDN1-positive cancers who have already tried standard treatments.

  Recruiting at 41 sites Phase 1/2 Alentis Therapeutics AG · Phoenix, Arizona and 40 other locations · NCT07169734

• Testing ATX-295 for advanced solid tumors and ovarian cancer

  This study is testing a new oral medication called ATX-295 to see if it is safe and effective for people with advanced solid tumors, including ovarian cancer.

  Recruiting at 11 sites Phase 1/2 Accent Therapeutics · Aurora, Colorado and 10 other locations · NCT06799065

• Investigating ALE.P02 for treating specific solid tumors in adults

  This study is testing a new treatment called ALE.P02 to see if it can safely help adults with advanced solid tumors that have a specific marker called Claudin-1.

  Recruiting at 39 sites Phase 1/2 Alentis Therapeutics AG · Scottsdale, Arizona and 40 other locations · NCT06747585

• Testing VLS-1488 for advanced cancers

  This study is testing a new oral medication called VLS-1488 to see if it is safe and effective for people with advanced solid tumors.

  Recruiting at 13 sites Phase 1/2 Volastra Therapeutics, Inc. · Los Angeles, California and 13 other locations · NCT05902988

• Testing AZD8205 for advanced solid tumors alone or with other cancer drugs

  This study is testing a new cancer drug called AZD8205, either by itself or with other treatments, to see how safe and effective it is for people with advanced solid tumors.

  Recruiting at 53 sites Phase 1/2 AstraZeneca · Duarte, California and 66 other locations · NCT05123482

Related topics

Quick answers

How many Squamous Non-small-cell Lung Cancer clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 21 countries. The most sites are in United States (6 trials), Italy (4 trials), Spain (4 trials), Taiwan (4 trials), France (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 5, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →